Intai Technology Corp. AI Stock Analysis
Intai Technology Corp. (4163) AI Stock Analysis
Intai Technology Corp.
(TPEx:4163)
Intai Technology scores in the middle of the range. The dominant factor is a mixed financial profile: a conservative balance sheet (debt-to-equity 0.54) and a strong cash flow recovery (free cash flow NT$287mn) are offset by three years of flat revenue and a sharp erosion in operating and net margins, with ROE down to 9.2%. Technicals are the weakest element, with the price below its 20-, 50- and 100-day moving averages and a negative MACD, though the oversold RSI and support from the 200-day average suggest the selling may be extended. Valuation is fair rather than cheap at 20.5x earnings, partially compensated by a 2.89% dividend yield and low volatility. Renewed revenue growth and restored operating leverage are needed to justify a higher score.
Intai Technology Corp. (4163) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 6.36B
- Dividend Yield
- 2.78%
- Average Volume (3M)
- 51.04K
- Price to Earnings (P/E)
- 20.7
- Beta (1Y)
- 0.25
- Revenue Growth
- 4.16%
- EPS Growth
- 40.82%
- Country
- TW
- Employees
- 460
- Sector
- General
- Sector Strength
- 55
- Industry
- Manufacturing - Tools & Accessories
Intai Technology Corp. Business Overview & Revenue Model
Company Description
INTAI Technology Corporation, established in 1988 and headquartered in Taichung, Taiwan, is a diversified manufacturer. The company specializes in providing a broad spectrum of products to various sectors, including automotive, aerospace, precision h...
Intai Technology Corp. Financial Statement Overview
Summary
A financially sound but operationally stagnant profile. Revenue has been flat near NT$2.4bn for three straight years, and although gross margin hit a record 44.3%, rising overhead has cut operating margin from 22.2% to 11.9% and net margin from 17.5% to 10.4% since 2022 (Income Statement: 57). The balance sheet is the key strength, with equity compounding to NT$2.71bn and debt-to-equity easing to 0.54, though return on equity has compressed to 9.2% (Balance Sheet: 70). Cash flow rebounded strongly, with operating cash flow up 72% to NT$472mn and free cash flow of NT$287mn backed by high earnings quality, but the multi-year volatility of free cash flow tempers the score (Cash Flow: 69).
Income Statement
57NeutralBalance Sheet
70PositiveCash Flow
69Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.49B | 2.41B | 2.38B | 2.44B | 2.41B | 1.97B |
| Gross Profit | 1.08B | 1.07B | 983.31M | 1.03B | 972.91M | 789.60M |
| EBITDA | 459.92M | 463.34M | 509.87M | 584.82M | 655.76M | 396.37M |
| Net Income | 299.47M | 249.60M | 259.89M | 340.58M | 422.33M | 228.44M |
Balance Sheet | ||||||
| Total Assets | 4.76B | 4.85B | 4.67B | 4.79B | 4.56B | 3.75B |
| Cash, Cash Equivalents and Short-Term Investments | 814.05M | 990.83M | 877.15M | 1.32B | 1.16B | 872.76M |
| Total Debt | 1.09B | 1.46B | 1.40B | 1.62B | 1.51B | 1.23B |
| Total Liabilities | 2.00B | 2.08B | 2.00B | 2.25B | 2.31B | 1.82B |
| Stockholders Equity | 2.70B | 2.71B | 2.61B | 2.47B | 2.25B | 1.93B |
Cash Flow | ||||||
| Free Cash Flow | 392.56M | 287.10M | 64.65M | 191.19M | 18.67M | -300.96M |
| Operating Cash Flow | 504.05M | 471.90M | 274.58M | 579.48M | 426.29M | 61.03M |
| Investing Cash Flow | -261.76M | -245.95M | -379.20M | -342.68M | -335.40M | -254.81M |
| Financing Cash Flow | -420.92M | -106.37M | -341.35M | -29.72M | 192.22M | 23.93M |
Intai Technology Corp. Peers Comparison
Overall Rating
TW:412668Neutral
TW:412968Neutral
TW:178863Neutral
TW:416760Neutral
TW:416359Neutral
TW:649933Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 68Neutral | TWD 5.39B | 12.54 | ― | 6.00% | 1.32% | 7.25% | |
| 68Neutral | TWD 7.01B | 12.73 | ― | 6.19% | 18.91% | 10.75% | |
| 63Neutral | TWD 5.57B | 14.19 | ― | 5.56% | 7.58% | 13.04% | |
| 60Neutral | TWD 6.30B | 7.86 | ― | 4.18% | -0.05% | 64.82% | |
| 59Neutral | TWD 6.41B | 20.66 | ― | 2.78% | 4.16% | 40.82% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 33Underperform | TWD 7.33B | -16.44 | ― | ― | 69.62% | 59.41% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:4163 | Intai Technology Corp. | 126.00 | 29.44 | 30.48% | |
| TW:1788 | Hi-Clearance Inc. | 126.00 | -4.42 | -3.39% | |
| TW:4126 | Pacific Hospital Supply Co., Ltd. | 75.00 | -8.60 | -10.29% | |
| TW:4129 | United Orthopedic Corporation | 72.70 | -42.36 | -36.82% | |
| TW:4167 | Savior Lifetec Corp. | 19.25 | 2.48 | 14.77% | |
| TW:6499 | Medeon Biodesign, Inc. | 73.80 | -23.20 | -23.92% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
